ProfileGDS4718 / 213320_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 53% 75% 58% 66% 88% 93% 68% 56% 71% 73% 61% 85% 91% 87% 76% 72% 87% 89% 69% 71% 71% 65% 72% 74% 86% 69% 87% 66% 88% 89% 80% 47% 59% 86% 87% 91% 65% 66% 80% 71% 90% 79% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9596671
GSM549102patient 115, normal, homogenized [OPG study]5.6957653
GSM549104patient 119, normal, homogenized [OPG study]7.3425875
GSM549108patient 138, normal, homogenized [OPG study]6.0359458
GSM549119patient 077, normal, homogenized [OPG study]6.539466
GSM549133patient 032, cancer, homogenized [OPG study]9.0157488
GSM549139patient 042, cancer, homogenized [OPG study]9.714693
GSM549099patient 107, normal, homogenized [OPG study]6.7034768
GSM549109patient 139, normal, homogenized [OPG study]5.8564356
GSM549110patient 046, normal, homogenized [OPG study]6.9564371
GSM549114patient 063, normal, homogenized [OPG study]7.1507973
GSM549122patient 082, normal, homogenized [OPG study]6.1935461
GSM549134patient 033, cancer, homogenized [OPG study]8.4765985
GSM549136patient 036, cancer, homogenized [OPG study]9.4377391
GSM549140patient 044, cancer, homogenized [OPG study]8.7967287
GSM549111patient 047, normal, homogenized [OPG study]7.5006576
GSM549113patient 057, normal, homogenized [OPG study]7.1297472
GSM549132patient 031, cancer, homogenized [OPG study]8.6690487
GSM549137patient 038, cancer, homogenized [OPG study]8.9874889
GSM549142patient 047, cancer, homogenized [OPG study]6.7483569
GSM549100patient 110, normal, homogenized [OPG study]6.8853271
GSM549107patient 135, normal, homogenized [OPG study]6.9754871
GSM549115patient 068, normal, homogenized [OPG study]6.5060165
GSM549116patient 072, normal, homogenized [OPG study]7.117372
GSM549120patient 078, normal, homogenized [OPG study]7.2317174
GSM549131patient 030, cancer, homogenized [OPG study]8.7608886
GSM549118patient 074, normal, homogenized [OPG study]6.7841569
GSM549129patient 027, cancer, homogenized [OPG study]8.6714687
GSM549123patient 088, normal, homogenized [OPG study]6.5777566
GSM549124patient 006, cancer, homogenized [OPG study]8.7408588
GSM549126patient 015, cancer, homogenized [OPG study]8.9163889
GSM549128patient 025, cancer, homogenized [OPG study]7.9262280
GSM549103patient 117, normal, homogenized [OPG study]5.4175147
GSM549117patient 073, normal, homogenized [OPG study]6.0130959
GSM549138patient 041, cancer, homogenized [OPG study]8.6380286
GSM549141patient 045, cancer, homogenized [OPG study]8.8492487
GSM549130patient 028, cancer, homogenized [OPG study]9.2599291
GSM549101patient 111, normal, homogenized [OPG study]6.4867865
GSM549105patient 128, normal, homogenized [OPG study]6.5287966
GSM549106patient 134, normal, homogenized [OPG study]7.9913180
GSM549112patient 048, normal, homogenized [OPG study]6.914171
GSM549125patient 011, cancer, homogenized [OPG study]9.1408190
GSM549127patient 024, cancer, homogenized [OPG study]7.8385779
GSM549135patient 035, cancer, homogenized [OPG study]9.2428790